What is Innovive?
Founded in 2004, Innovive specializes in the design and manufacturing of reliable disposable rodent caging systems. Their advanced processes aim to provide research facilities with superior quality, performance, and cost savings. The company's products undergo independent testing and validation to ensure trouble-free operation, supported by a global manufacturing and distribution network that facilitates advantageous pricing and rapid order fulfillment. Innovive's core mission is to radically transform the economics and convenience associated with laboratory animal research.
How much funding has Innovive raised?
Innovive has raised a total of $16M across 2 funding rounds:
Other Financing Round
$15M
Debt
$1M
Other Financing Round (2007): $15M with participation from Paramount BioCapital Asset Management
Debt (2020): $1M led by PPP
Key Investors in Innovive
Paramount BioCapital Asset Management
Paramount BioCapital Asset Management is an entity that participated in an earlier financing round for Innovive, suggesting a historical interest in the company's biotechnology or life sciences ventures.
PPP
Public-Private Partnership
What's next for Innovive?
The substantial enterprise-level funding and recent strategic investment indicate a strong growth trajectory for Innovive. This capital infusion is likely to fuel further expansion of its manufacturing capabilities, enhance its product development pipeline for disposable rodent caging systems, and broaden its market reach within the global research community. The company's focus on cost savings and performance for research facilities positions it for continued success in a critical scientific sector.
See full Innovive company page
